opioids Archives -

Registrations Closing Soon

Registration is closing soon for SMi’s 22nd Annual Pain Therapeutics Conference

https://pharmaphorum.com/partner-content/registration-is-closing-soon-for-smis-22nd-annual-pain-therapeutics-conference/

Events/ Events

SMi’s 22nd Annual Pain Therapeutics Conference

ssapal@smi-online.co.uk Analgesic, Chronic pain, Neuropathic pain, opioids, Pain Therapeutics 0 Comment

Pain Therapeutics Conference

SMi’s 22nd Annual Pain Therapeutics Conference

https://pharmaphorum.com/events/smis-22nd-annual-pain-therapeutics-conference/

Tablets on dollar bills (treatment, addiction, aging - concept).

News/ News/ Sales and Marketing

Collegium agrees $604m buyout of pain specialist BDSI

Phil Taylor BioDelivery Sciences International, Collegium Pharma, M&A, opioids 0 Comment

Collegium Pharma has expanded its pain franchise though a deal to acquire BioDelivery Sciences International (BDSI), which has

Collegium agrees $604m buyout of pain specialist BDSI

https://pharmaphorum.com/news/collegium-agrees-604m-buyout-of-pain-specialist-bdsi/

Digital/ News/ News

Digital therapeutic cuts opioid use disorder care costs, says study

Phil Taylor digital, digital health, opioid use disorder, opioids, PEAR Therapeutics 0 Comment

A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it

Digital therapeutic cuts opioid use disorder care costs, says study

https://pharmaphorum.com/news/digital-therapeutic-cuts-opioid-use-disorder-care-costs-says-study/

Market Access/ News/ News

Indivior pays $300m to settle Suboxone marketing allegations

Richard Staines Indivior, opioid addication, opioids, Suboxone 0 Comment

Indivior has paid out $300 million to resolve civil claims from US states after it was last year

Indivior pays $300m to settle Suboxone marketing allegations

https://pharmaphorum.com/news/indivior-pays-300m-to-settle-suboxone-marketing-allegations/

doctor is sending result of medical test to patient

Digital/ News/ News

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

Richard Staines digital therapeutics, opioids, PEAR Therapeutics 0 Comment

A third US state has agreed to fund Pear Therapeutics’ digital therapeutics (DTx) to treat people with substance

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

https://pharmaphorum.com/news/ohio-is-third-state-to-fund-pears-digital-therapeutics-to-tackle-addiction/

Partner content/ Press releases

Top-Level industry professionals to speak at Pain Therapeutics Conference in 2 weeks

ssapal@smi-online.co.uk Analgesic, Chronic pain, opioids, pain research, Pain Therapeutics 0 Comment

2 weeks Pain Therapeutics Conference – expert speakers

Top-Level industry professionals to speak at Pain Therapeutics Conference in 2 weeks

https://pharmaphorum.com/partner-content/top-level-industry-professionals-to-speak-at-pain-therapeutics-conference-in-2-weeks/

Partner content/ Press releases

Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference

ssapal@smi-online.co.uk Analgesic, Chronic pain, opioids, pain clinical trials, Pain Therapeutics 0 Comment

Registration Opens SMi’s Pain Therapeutics

Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference

https://pharmaphorum.com/partner-content/registration-opens-for-smis-20th-annual-pain-therapeutics-conference/

News

Washington State is latest to sue Janssen over opioid marketing

Richard Staines Johnson & Johnson, litigation, opioids 0 Comment

Washington State has become the latest to sue Johnson & Johnson over the way it marketed opioid painkillers,

Washington State is latest to sue Janssen over opioid marketing

https://pharmaphorum.com/news/washington-state-is-latest-to-sue-jj-over-opioid-marketing/

Trending

opioids

Login